Human cytomegalovirus immediate early proteins and cell growth control

Gene

Volumn 290, Issue 1-2, 2002, Pages 19-34

  Castillo, Jonathan P ^a   Kowalik, Timothy F ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Apoptosis; Cell cycle; Human cytomegalovirus; Immediate early proteins; p53; Retinoblastoma

Indexed keywords

CALMODULIN BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN DEPENDENT KINASE; E1A PROTEIN; GENE PRODUCT; IMMEDIATE EARLY PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 3; ONCOPROTEIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN C JUN; PROTEIN IE55; PROTEIN IE72; PROTEIN IE86; PROTEIN IRS1; PROTEIN MCM7; PROTEIN MDM2; PROTEIN P107; PROTEIN P21; PROTEIN P53; PROTEIN TEF 1; PROTEIN TRS1; PROTEIN UL122; RETINOBLASTOMA PROTEIN; SUMO 1 PROTEIN; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR EGR 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS PROTEIN; VIRUS TEGUMENT PROTEIN;

ADENOVIRUS; ALTERNATIVE RNA SPLICING; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; DNA REPLICATION; EXON; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN CYTOMEGALOVIRUS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

APOPTOSIS; CELL CYCLE; CYTOMEGALOVIRUS; EUKARYOTIC CELLS; HUMANS; IMMEDIATE-EARLY PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; VIRUS REPLICATION;

ADENOVIRIDAE; CYTOMEGALOVIRUS; DNA VIRUSES; HERPESVIRIDAE; HUMAN HERPESVIRUS 5; PAPILLOMAVIRUS; SIMIAE; SIMIAN VIRUS 40;

EID: 0037094414     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(02)00566-8     Document Type: Review

References (123)

1. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells
2. Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML
3. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10)
4. Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9
5. Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus
6. HCMV IE1 (IE72) targets E2Fs to stimulate cell cycle
7. Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle
8. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53
9. Infection of fibroblast lines expressing functional immediate early proteins by HCMV pp71 mutant CR223
10. Transformation of hamster embryonic fibroblast cells by UV-irradiated human cytomegalovirus
11. Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function
12. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1
13. The human cytomegalovirus 86-kilodalton major immediate-early protein interacts physically and functionally with histone acetyltransferase P/CAF
14. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies
15. HCMV IE1-72 activates p53 through multiple pathways to induce a host growth arrest response
16. Role of human cytomegalovirus immediate-early proteins in cell growth control
17. The human cytomegalovirus 86 K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation
18. Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element
19. Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus
20. The retinoblastoma gene product negatively regulates transcriptional activation mediated by the human cytomegalovirus IE2 protein
21. Characterization of a viable HCMV recombinant virus with an internal deletion of the IE2 86 gene corresponding to amino acids 136-290
22. Human cytomegalovirus UL37 immediate-early regulatory proteins traffic through the secretory apparatus and to mitochondria
23. Human cytomegalovirus infection inhibits G1/S transition
24. Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate
25. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure
26. Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other
27. Oncogenic transformation of human embryo lung cells by human cytomegalovirus
28. The CHL 1 (CTF 1) gene product of Saccharomyces cerevisiae is important for chromosome transmission and normal cell cycle progression in G2/M
29. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2
30. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1
31. Hormone dependent replication of a human cytomegalovirus recombinant encoding an IE2-estrogen receptor fusion protein
32. Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant
33. The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate early gene transactivates heterologous promoters in a TATA box independent mechanism and interacts directly with TFIID
34. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein
35. An anti-apoptotic protein of human cytomegalovirus enables virus replication
36. Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle
37. CCAAT box-dependent activation of the TATA-less human DNA polymerase alpha promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein
38. Identification of an HCMV IE2 temperature-sensitive allele
39. Intracellular localization and expression of the human cytomegalovirus matrix phosphoprotein pp71 (ppUL82): Evidence for its translocation into the nucleus
40. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b
41. Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein hDaxx
42. SUMO-1 modification of the IE2-86 transactivator is required for efficient replication of human cytomegalovirus
43. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1
44. Inter- and intracellular traffic of HCMV tegument protein pp71
45. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest
46. Domain mapping of the human cytomegalovirus IE1-72 and cellular p107 protein-protein interaction and the possible functional consequences
47. Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box
48. Human cytomegalovirus IE86 protein interacts with promoter-bound TATA- binding protein via a specific region distinct from the autorepression domain
49. The HCMV protein pp71 induces DNA synthesis in quiescent cells by targeting members of the RB family of tumor suppressor for degradation
50. Mutations that abolish the ability of HCMV pp71 protein to induce DNA synthesis in quiescent cells do not affect its ability to accelerate G1 phase cell cycle progression
51. Transactivation activity of the human cytomegalovirus IE2 protein occurs at steps subsequent to TATA box-binding protein recruitment
52. Human cytomegalovirus IE1 protein activates AP-1 through a cellular protein kinase(s)
53. In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins
54. The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1
55. Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB
56. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis
57. Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S
58. Human cytomegalovirus UL69 protein induces cells to accumulate in G1 phase of the cell cycle
59. Effects of human cytomegalovirus major immediate-early proteins in controlling the cell cycle and inhibiting apoptosis: Studies with ts13 cells
60. Transcriptional activation by the human cytomegalovirus immediate-early proteins: Requirements for simple promoter structures and interactions with multiple components of the transcription complex
61. TAF-like functions of human cytomegalovirus immediate-early proteins
62. Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: Mutational analysis of the viral proteins
63. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes
64. Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription
65. Nuclear domain 10, the site of DNA virus transcription and replication
66. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0)
67. Review: Properties and assembly mechanisms of ND10, PML bodies, or PODs
68. Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53
69. Cytomegaloviruses and their replication
70. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus
71. C-Jun and p53 activity is modulated by SUMO-1 modification
72. Human cytomegalovirus IE86 protein induction of a cell cycle halt and interaction with members of the MCM protein family
73. The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells
74. Toward an understanding of the functional complexity of the E2F and retinoblastoma families
75. Functional analysis of E2F transcription factor
76. Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins
77. Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication
78. Open reading frames UL44, IRS1/TRS1, and UL36-38 are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA synthesis
79. Cytomegalovirus
80. The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site
81. The functionally active IE2 immediate-early regulatory protein of human cytomegalovirus is an 80-kilodalton polypeptide that contains two distinct activator domains and a duplicated nuclear localization signal
82. The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter
83. Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus
84. SUMO-1 modification activates the transcriptional response of p53
85. Characterization of the human cytomegalovirus irs1 and trs1 genes: A second immediate-early transcription unit within irs1 whose product antagonizes transcriptional activation
86. PIRS1 and pTRS1 are present in human cytomegalovirus virions
87. Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus
88. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells
89. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
90. Site-specific binding of the human cytomegalovirus IE2 86-kilodalton protein to an early gene promoter
91. CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter
92. The human cytomegalovirus IE2 86-kilodalton protein interacts with an early gene promoter via site-specific DNA binding and protein-protein associations
93. High rate of concurrent genital infections with human cytomegalovirus and human papillomaviruses in cervical cancer patients
94. Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate "hit-and-run" oncogenic transformation in cooperation with the adenovirus E1A proteins
95. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation
96. Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein
97. Protein-protein interactions between human cytomegalovirus IE2-580aa and pUL84 in lytically infected cells
98. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis
99. Interaction of human cytomegalovirus with p53: Possible role in coronary restenosis
100. Characterization of SUMO-1 modified HCMV IE72
101. Structural analysis of the major immediate early gene of human cytomegalovirus
102. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration
103. Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells
104. Expression of the human cytomegalovirus UL36-38 immediate early region during permissive infection
105. Sibling rivalry in the E2F family
106. Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53
107. A 10-base-pair element of the human immunodeficiency virus type 1 long terminal repeat (LTR) is an absolute requirement for transactivation by the human cytomegalovirus 72-kilodalton IE1 protein but can be compensated for by other LTR regions in transactivation by the 80-kilodalton IE2 protein
108. Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G(1)
109. The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation
110. A specific subform of the human cytomegalovirus transactivator protein pUL69 is contained within the tegument of virus particles
111. UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression
112. Functional interaction between pleiotropic transactivator pUL69 of human cytomegalovirus and the human homolog of yeast chromatin regulatory protein SPT6
113. The HCMV 72-KDa major immediate early protein interacts physically and functionally with a constituent of ND10 bodies, hDAXX
114. Mutations of the human cytomegalovirus immediate-early 2 protein defines regions and amino acid motifs important in transactivation of transcription from the HIV-1 LTR promoter
115. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein
116. The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site
117. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters
118. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters
119. Role of SUMO-1-modified PML in nuclear body formation
120. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy
121. Human cytomegalovirus IE1 and IE2 proteins block apoptosis